Clinical Trial Update: Pharmacogenomically Selected Treatment for Gastric and Gastroesophageal Junction (GEJ) Tumors [Phase 2]

View source ↗

Summary

Phase 2 trial update on pharmacogenomically selected treatment for gastric and GEJ tumors; results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Gastric Cancer

Snippet

Sponsor: Vanderbilt University | Conditions: Stomach Neoplasms, Esophageal Neoplasms | Phase 2 | Status: COMPLETED | Results posted: 2015-02-27